CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- 4 Open-market sale Chief Medical Officer sold 1,848 shares at $16.24 ($30,012)
- 4 Grant or award Chief Financial Officer acquired 21,000 shares (grant or award)
- SC 13G Stake Amended Statement of Ownership
- 4 Planned sale President and CEO sold 75,000 shares at $20.08 ($1,506,000)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Option exercise Chief Development Officer acquired 20,000 shares (option exercise)
- 4 Option exercise President and CEO acquired 6,000 shares (option exercise)
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Delisting notice
- 4 Shares withheld for taxes Chief Development Officer gave up 4,150 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 12,165 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,150 shares (to pay taxes)
Page 13 of 36 · 707 filings